<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>52</viewCount><searchCount>0</searchCount></scores><additional><submitter>Lemaitre RN</submitter><funding>NCATS NIH HHS</funding><funding>NIA NIH HHS</funding><funding>NCRR NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NHGRI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>176-84</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4274065</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>56(1)</volume><pubmed_abstract>Very long-chain saturated fatty acids (VLSFAs) are saturated fatty acids with 20 or more carbons. In contrast to the more abundant saturated fatty acids, such as palmitic acid, there is growing evidence that circulating VLSFAs may have beneficial biological properties. Whether genetic factors influence circulating levels of VLSFAs is not known. We investigated the association of common genetic variation with plasma phospholipid/erythrocyte levels of three VLSFAs by performing genome-wide association studies in seven population-based cohorts comprising 10,129 subjects of European ancestry. We observed associations of circulating VLSFA concentrations with common variants in two genes, serine palmitoyl-transferase long-chain base subunit 3 (SPTLC3), a gene involved in the rate-limiting step of de novo sphingolipid synthesis, and ceramide synthase 4 (CERS4). The SPTLC3 variant at rs680379 was associated with higher arachidic acid (20:0 , P = 5.81 × 10(-13)). The CERS4 variant at rs2100944 was associated with higher levels of 20:0 (P = 2.65 × 10(-40)) and in analyses that adjusted for 20:0, with lower levels of behenic acid (P = 4.22 × 10(-26)) and lignoceric acid (P = 3.20 × 10(-21)). These novel associations suggest an inter-relationship of circulating VLSFAs and sphingolipid synthesis.</pubmed_abstract><journal>Journal of lipid research</journal><pubmed_title>Genetic loci associated with circulating levels of very long-chain saturated fatty acids.</pubmed_title><pmcid>PMC4274065</pmcid><funding_grant_id>HHSN268201300028C</funding_grant_id><funding_grant_id>U01 HG004424</funding_grant_id><funding_grant_id>R01 HL043851</funding_grant_id><funding_grant_id>P01 CA087969</funding_grant_id><funding_grant_id>N01HC95159</funding_grant_id><funding_grant_id>R01 HL059367</funding_grant_id><funding_grant_id>HHSN268201100009I</funding_grant_id><funding_grant_id>R01 AG023629</funding_grant_id><funding_grant_id>HHSN268201100005C</funding_grant_id><funding_grant_id>R01 HL060712</funding_grant_id><funding_grant_id>UL1 RR025005</funding_grant_id><funding_grant_id>HHSN268201100009C</funding_grant_id><funding_grant_id>UL1 RR024156</funding_grant_id><funding_grant_id>HHSN268201100005I</funding_grant_id><funding_grant_id>HHSN268201100005G</funding_grant_id><funding_grant_id>HHSN268201300027C</funding_grant_id><funding_grant_id>UL1 TR000124</funding_grant_id><funding_grant_id>R01 HL120393</funding_grant_id><funding_grant_id>HHSN268200800007C</funding_grant_id><funding_grant_id>HHSN268201100006C</funding_grant_id><funding_grant_id>R01 HL035464</funding_grant_id><funding_grant_id>N01HC85079</funding_grant_id><funding_grant_id>P30 DK063491</funding_grant_id><funding_grant_id>HHSN268201100010C</funding_grant_id><funding_grant_id>R01 HL086694</funding_grant_id><funding_grant_id>U01 HG004402</funding_grant_id><funding_grant_id>U01 HG004446</funding_grant_id><funding_grant_id>UM1 CA182913</funding_grant_id><funding_grant_id>HHSN268201100011I</funding_grant_id><funding_grant_id>U01 HL080295</funding_grant_id><funding_grant_id>HHSN268201300026C</funding_grant_id><funding_grant_id>N01HC85081</funding_grant_id><funding_grant_id>HHSN268200900041C</funding_grant_id><funding_grant_id>N01HC85082</funding_grant_id><funding_grant_id>UM1 CA167552</funding_grant_id><funding_grant_id>R01 HL085710</funding_grant_id><funding_grant_id>N01HC85080</funding_grant_id><funding_grant_id>HHSN268201200036C</funding_grant_id><funding_grant_id>R00 HL098459</funding_grant_id><funding_grant_id>HHSN268201100007C</funding_grant_id><funding_grant_id>N01HC85086</funding_grant_id><funding_grant_id>N01HC85083</funding_grant_id><funding_grant_id>R01 CA047988</funding_grant_id><funding_grant_id>R01 HL080467</funding_grant_id><funding_grant_id>P01 CA055075</funding_grant_id><funding_grant_id>HHSN268201100011C</funding_grant_id><funding_grant_id>U01 HG004729</funding_grant_id><funding_grant_id>R01 HL087652</funding_grant_id><funding_grant_id>HHSN268201100007I</funding_grant_id><funding_grant_id>HHSN268201300029C</funding_grant_id><funding_grant_id>HHSN268201300025C</funding_grant_id><funding_grant_id>N01HC95169</funding_grant_id><funding_grant_id>HL105756</funding_grant_id><funding_grant_id>N01HC55222</funding_grant_id><funding_grant_id>R00 HL095649</funding_grant_id><funding_grant_id>R01 HL034594</funding_grant_id><funding_grant_id>N02HL64278</funding_grant_id><funding_grant_id>HHSN268201100008C</funding_grant_id><funding_grant_id>R01 HL103612</funding_grant_id><funding_grant_id>R01 HL084099</funding_grant_id><funding_grant_id>R01 HL105756</funding_grant_id><funding_grant_id>HHSN268201100008I</funding_grant_id><funding_grant_id>R01 HL087641</funding_grant_id><funding_grant_id>HHSN268201100012C</funding_grant_id><pubmed_authors>Kabagambe EK</pubmed_authors><pubmed_authors>Psaty BM</pubmed_authors><pubmed_authors>Weng LC</pubmed_authors><pubmed_authors>Siscovick DS</pubmed_authors><pubmed_authors>Chen YD</pubmed_authors><pubmed_authors>Djousse L</pubmed_authors><pubmed_authors>Rich SS</pubmed_authors><pubmed_authors>Chu AY</pubmed_authors><pubmed_authors>Chasman DI</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Wu H</pubmed_authors><pubmed_authors>Foy M</pubmed_authors><pubmed_authors>Sun Q</pubmed_authors><pubmed_authors>Mozaffarian D</pubmed_authors><pubmed_authors>Lemaitre RN</pubmed_authors><pubmed_authors>Arnett DK</pubmed_authors><pubmed_authors>Tang W</pubmed_authors><pubmed_authors>Jensen MK</pubmed_authors><pubmed_authors>Wu JH</pubmed_authors><pubmed_authors>Ridker PM</pubmed_authors><pubmed_authors>Hu FB</pubmed_authors><pubmed_authors>Tsai MY</pubmed_authors><pubmed_authors>Steffen L</pubmed_authors><pubmed_authors>Guan W</pubmed_authors><pubmed_authors>Zhu J</pubmed_authors><pubmed_authors>Manichaikul A</pubmed_authors><pubmed_authors>McKnight B</pubmed_authors><pubmed_authors>Rimm EB</pubmed_authors><pubmed_authors>Jacobs DR</pubmed_authors><pubmed_authors>Fornage M</pubmed_authors><pubmed_authors>King IB</pubmed_authors><pubmed_authors>Friedlander Y</pubmed_authors><view_count>52</view_count></additional><is_claimable>false</is_claimable><name>Genetic loci associated with circulating levels of very long-chain saturated fatty acids.</name><description>Very long-chain saturated fatty acids (VLSFAs) are saturated fatty acids with 20 or more carbons. In contrast to the more abundant saturated fatty acids, such as palmitic acid, there is growing evidence that circulating VLSFAs may have beneficial biological properties. Whether genetic factors influence circulating levels of VLSFAs is not known. We investigated the association of common genetic variation with plasma phospholipid/erythrocyte levels of three VLSFAs by performing genome-wide association studies in seven population-based cohorts comprising 10,129 subjects of European ancestry. We observed associations of circulating VLSFA concentrations with common variants in two genes, serine palmitoyl-transferase long-chain base subunit 3 (SPTLC3), a gene involved in the rate-limiting step of de novo sphingolipid synthesis, and ceramide synthase 4 (CERS4). The SPTLC3 variant at rs680379 was associated with higher arachidic acid (20:0 , P = 5.81 × 10(-13)). The CERS4 variant at rs2100944 was associated with higher levels of 20:0 (P = 2.65 × 10(-40)) and in analyses that adjusted for 20:0, with lower levels of behenic acid (P = 4.22 × 10(-26)) and lignoceric acid (P = 3.20 × 10(-21)). These novel associations suggest an inter-relationship of circulating VLSFAs and sphingolipid synthesis.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jan</publication><modification>2024-10-14T22:44:30.627Z</modification><creation>2019-03-27T01:42:13Z</creation></dates><accession>S-EPMC4274065</accession><cross_references><pubmed>25378659</pubmed><doi>10.1194/jlr.M052456</doi></cross_references></HashMap>